B-cell activity markers are associated with different disease activity domains in primary Sjögren’s syndrome

Faculty Opinions recommendation of B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732962337.793564238 ◽

2019 ◽

Author(s):

William St Clair

Keyword(s):

Disease Activity ◽

B Cell ◽

Sjögren's Syndrome ◽

Cell Activity ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren’s syndrome (pSS) via suppressing NF-κb signaling pathway

Molecular and Cellular Biochemistry ◽

10.1007/s11010-021-04070-z ◽

2021 ◽

Author(s):

Hong Zhu ◽

Jian Zheng ◽

Yan Zhou ◽

Tong Wu ◽

Tiantian Zhu

Keyword(s):

B Cell ◽

Signaling Pathway ◽

Sjögren’S Syndrome ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

High circulating level of interleukin-18 in patients with primary Sjögren's syndrome is associated with disease activity

Modern Rheumatology ◽

10.3109/14397595.2015.1021409 ◽

2015 ◽

Vol 26 (1) ◽

pp. 156-158 ◽

Cited By ~ 2

Author(s):

Yan Chen ◽

Fengyuan Deng ◽

Junfeng Zheng ◽

Junping Yin ◽

Renliang Huang ◽

...

Keyword(s):

Disease Activity ◽

Sjögren’S Syndrome ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

Interleukin 18 ◽

Whole-volume ADC Histogram and Texture Analyses of Parotid Glands as an Image Biomarker in Evaluating Disease Activity of Primary Sjögren’s Syndrome

Scientific Reports ◽

10.1038/s41598-018-33797-x ◽

2018 ◽

Vol 8 (1) ◽

Cited By ~ 4

Author(s):

Chen Chu ◽

Fengxian Wang ◽

Huayong Zhang ◽

Yun Zhu ◽

Chun Wang ◽

...

Keyword(s):

Disease Activity ◽

Sjögren’S Syndrome ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

Parotid Glands ◽

SAT0292 Serum and Salivary Cytokines and Chemokines Levels as Disease Activity Biomarkers in Patients with Primary Sjögren's Syndrome

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.5331 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 774.1-774

Author(s):

A.A. Tzec Pérez ◽

R.E. Barbosa Cobos ◽

G.E. Lugo Zamudio ◽

L.T. Becerril Mendoza ◽

M.A. Moreno Eutimio ◽

...

Keyword(s):

Disease Activity ◽

Sjögren’S Syndrome ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

Cytokines And Chemokines ◽

AB0509 Identification of novel biomarkers associated with disease activity of primary sjÖgren's syndrome and clinical response to vay736

10.1136/annrheumdis-2017-eular.4736 ◽

2017 ◽

Author(s):

J Doucet ◽

R Kazma ◽

M Cabanski ◽

E Kamphausen ◽

P Maguire ◽

...

Keyword(s):

Disease Activity ◽

Clinical Response ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

Novel Biomarkers ◽

Looking into the Future—The EULAR Disease Activity Scores: Toward a Consensual Evaluation of Primary Sjogren’s Syndrome

Sjögren’s Syndrome ◽

10.1007/978-1-60327-957-4_30 ◽

2011 ◽

pp. 443-454

Author(s):

Raphaèle Seror ◽

Philippe Ravaud ◽

Claudio Vitali ◽

Simon J. Bowman ◽

Xavier Mariette

Keyword(s):

Disease Activity ◽

Sjögren’S Syndrome ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

The Future ◽

Increased frequency of CCR7+CD4+ T cells from patients with primary Sjögren's syndrome: An indicator of disease activity rather than of damage severity

Cytokine ◽

10.1016/j.cyto.2018.04.015 ◽

2018 ◽

Vol 110 ◽

pp. 9-17 ◽

Cited By ~ 3

Author(s):

Chunling Wu ◽

Pingting Yang ◽

Haina Liu ◽

Weiguo Xiao ◽

Lijuan Zhao

Keyword(s):

T Cells ◽

Disease Activity ◽

Cd4 T Cells ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome

Annals of the Rheumatic Diseases ◽

10.1136/ard.2006.057919 ◽

2007 ◽

Vol 66 (3) ◽

pp. 351-357 ◽

Cited By ~ 196

Author(s):

R. Seror ◽

C. Sordet ◽

L. Guillevin ◽

E. Hachulla ◽

C. Masson ◽

...

Keyword(s):

B Cell ◽

Sjögren’S Syndrome ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

Systemic Complications ◽

Clinical efficacy of leflunomide in primary Sjögren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2011-201026 ◽

2012 ◽

Vol 71 (12) ◽

pp. 1934-1941 ◽

Cited By ~ 8

Author(s):

Angela Bikker ◽

Jan-Maarten van Woerkom ◽

Aike A Kruize ◽

Kim M G van der Wurff-Jacobs ◽

Johannes W J Bijlsma ◽

...

Keyword(s):

T Cell ◽

Clinical Efficacy ◽

Sjögren's Syndrome ◽

Cell Activity ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽